References
- Merlini G, Dispenzieri A, Sanchorawala V, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 2018;4(1):38.
- Kastritis E, Wechalekar AD, Dimopoulos MA, et al. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol. 2010;28(6):1031–1037.
- Wang AK, Fealey RD, Gehrking TL, et al. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc. 2008;83(11):1226–1230.
- Matsuda M, Gono T, Morita H, et al. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. Eur J Neurol. 2011;18(4):604–610.
- Sturm D, Schmidt-Wilcke T, Greiner T, et al. Confocal cornea microscopy detects involvement of corneal nerve fibers in a patient with light-chain amyloid neuropathy caused by multiple myeloma: a case report. Case Rep Neurol. 2016;8(2):134–139.
- Ebenezer GJ, Liu Y, Judge DP, et al. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy. Ann Neurol. 2017;82(1):44–56.
- Lauria G, Cornblath DR, Johansson O, et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol. 2005;12(10):747–758.
- Tobin K, Giuliani MJ, Lacomis D. Comparison of different modalities for detection of small fiber neuropathy. Clin Neurophysiol. 1999;110(11):1909–1912.
- Griffin JW, Hsieh ST, McArthur JC, et al. Laboratory testing in peripheral nerve disease. Neurol Clin. 1996;14(1):119–133.
- Uceyler N, Kahn AK, Kramer D, et al. Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. BMC Neurol. 2013;13:47.
- Chao CC, Hsueh HW, Kan HW, et al. Skin nerve pathology: biomarkers of premanifest and manifest amyloid neuropathy. Ann Neurol. 2019;85(4):560–573.
- Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590–596.
- Penaz J. Photoelectric measurement of blood pressure, volume and flow in the finger. Digest of the International Conference on Medicine and Biological Engineering, Conference Committee of the 10th International Conference on Medicine and Biological Engineering; 1973; Dresden, Germany.
- Parati G, Casadei R, Groppelli A, et al. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989;13(6):647–655.
- Imholz BP, Settels JJ, van der Meiracker AH, et al. Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intra-arterial pressure. Cardiovasc Res. 1990;24(3):214–221.
- Panerai R, James M, Potter J, et al. Baroreceptor sensitivity in human subjects: sequence or spectral analysis? Comput Cardiol. 1995;305–308.
- Panerai RB, James MA, Potter JF. Impulse response analysis of baroreceptor sensitivity. Am J Physiol. 1997;272(4 Pt 2):H1866–H1875.
- Robinson TG, James M, Youde J, et al. Cardiac baroreceptor sensitivity is impaired after acute stroke. Stroke 1997;28(9):1671–1676.
- Mold JW, Vesely SK, Keyl BA, et al. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004;17(5):309–317.
- Kollmer J, Weiler M, Purrucker J, et al. MR neurography biomarkers to characterize peripheral neuropathy in AL amyloidosis. Neurology. 2018;91(7):e625–e634.
- Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Autonomic evaluation is independent of somatic evaluation for small fiber neuropathy. J Neurol Sci. 2014;344(1–2):51–54.
- Sohn EH, Song KS, Lee JY, et al. Comparison of somatic and sudomotor nerve fibers in type 2 diabetes mellitus. J Clin Neurol. 2017;13(4):366–370.
- Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131(7):1912–1925.
- Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29(6):1294–1299.
- Valcour V, Yeh TM, Bartt R, et al.; the AIDS Clinical Trials Group (ACTG) 5157 protocol team. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. HIV Med. 2009;10(2):103–110.
- Schiffmann R, Hauer P, Freeman B, et al. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve. 2006;34(1):53–56.